CardiNor at ESC Congress: New research highlights the potential of secretoneurin

ESC Congress 2026 in Munich will bring together leading experts in cardiovascular medicine, with new research on secretoneurin among the scientific highlights. CardiNor is pleased to be part of the congress alongside our collaborators at Akershus University Hospital.
Date
Time
Location
Munich, Germany
CardiNor Involvement
Attending
CardiNor is excited to participate in the ESC Congress 2026 in Munich. As part of the congress, our collaborators at Akershus University Hospital will present two posters highlighting new findings on secretoneurin and its potential role in cardiovascular risk assessment and patient outcomes.
The posters are titled:
"Circulating secretoneurin concentrations predict cardiac arrhythmia and mortality in patients with acute tachypnea: Data from the Akershus Cardiac Examination 4 Study"
"Circulating secretoneurin concentrations predicts mortality and heart failure hospitalizations but not ventricular arrhythmias in stable ICD outpatients"
Representing CardiNor at ESC Congress will be CCO Elin Godager and CSO Paula Lindner. They will be attending the congress to meet with collaborators, researchers and industry colleagues, and to further strengthen CardiNor’s presence within the international cardiovascular community.
We look forward to an inspiring weekend of scientific exchange, new insights and valuable conversations in Munich.



